Summary
Bristol Myers Squibb (BMY) filed its first-quarter 2021 10-Q report on April 28, 2021, detailing financial performance for the period ending March 30, 2021. The company demonstrated continued revenue growth driven by key products, indicating strong commercial execution following recent acquisitions. Investors should note the ongoing integration efforts and the impact of these on the company's overall financial health and future outlook. While specific figures are not provided in the excerpt, the report's structure suggests a focus on operational results, financial condition, and risk factors pertinent to the current business environment.
Financial Highlights
57 data pointsBeta
Financial Statements
Beta
| Revenue | $11.07B |
| Cost of Revenue | $2.84B |
| Gross Profit | $8.23B |
| R&D Expenses | $2.22B |
| SG&A Expenses | $1.67B |
| Operating Expenses | $8.54B |
| Interest Expense | $353.00M |
| Net Income | $2.02B |
| EPS (Basic) | $0.90 |
| EPS (Diluted) | $0.89 |
| Shares Outstanding (Basic) | 2.24B |
| Shares Outstanding (Diluted) | 2.27B |
Key Highlights
- 1The report covers the financial performance for the first quarter of 2021, ending March 30, 2021.
- 2Key financial statements including Consolidated Statements of Earnings, Balance Sheets, and Cash Flows are presented.
- 3Management's Discussion and Analysis provides insights into the company's financial condition and results of operations.
- 4Disclosure regarding Market Risk and Controls and Procedures are included.
- 5Information on Legal Proceedings and Risk Factors is available, offering transparency on potential challenges.
- 6Exhibits and other supplementary information are provided to give a comprehensive view of the company's filings.
Frequently Asked Questions
While the provided excerpt does not contain specific revenue figures, the report details the Consolidated Statements of Earnings, which would outline the company's top-line performance and revenue drivers for the period ending March 30, 2021.
The 'Management’s Discussion and Analysis of Financial Condition and Results of Operations' section is the primary area to review for insights into how BMY is managing its financial condition, including the integration and financial impact of recent acquisitions. The Consolidated Balance Sheets will also provide a snapshot of the company's assets, liabilities, and equity.
Item 1A, 'Risk Factors,' and Item 1, 'Legal Proceedings,' in Part II of the report are dedicated to disclosing potential risks and ongoing legal matters that could impact the company's financial performance and operations.
The 'Consolidated Statements of Cash Flows' in Part I of the filing provides a detailed breakdown of the company's cash inflows and outflows from operating, investing, and financing activities during the first quarter of 2021.